Kimi K2.5 Outperforms Opus 4.6 on Hallucination Test in Pharma: A New LLM Champion?
research#llm📝 Blog|Analyzed: Feb 20, 2026 13:17•
Published: Feb 20, 2026 11:54
•1 min read
•r/LocalLLaMAAnalysis
This is exciting news! Kimi K2.5 is showing impressive performance in a real-world pharmaceutical use case, especially when compared to its commercial counterparts. This suggests remarkable progress in addressing the crucial issue of "Hallucination" (幻覚) within "Large Language Model" (大規模言語モデル) (LLM) (大语言模型) technology.
Key Takeaways
- •Kimi K2.5 demonstrated superior performance on a "Hallucination" (幻覚) (幻觉) benchmark in the pharmaceutical industry.
- •Opus 4.6 showed a higher "Hallucination" (幻覚) (幻觉) rate, according to the benchmark.
- •The benchmark used realistic data from the pharmaceutical domain.
Reference / Citation
View Original"Kimi K2.5 did much better (albeit still not great)."